Predict™ In Silico Tox Service
Innovative Biotech Company Reduces Development Program Timelines for Neurogenerative Disease Research Program
Setting New Standards in Computational Toxicology
The client is an innovative clinical-stage drug platform company, who have a specific focus in the development of medication to treat neurogenerative diseases.
Learn how they successfully deployed Instem’s Predict™ In Silico Tox Service to significantly reduce their development program timelines.